Naturally my post as all other posts on BG is on the basis of positive data. Please refer 10.2 of the 2015 AGM Presentation 20/11/2015:
![]()
http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=obj&timeframe=Y&year=2015
Also refer Annual Report to Shareholders, 25/09/2015, page 5:
![]()
http://www.asx.com.au/asxpdf/20150925/pdf/431ldghxk48bjq.pdf
And also refer Investor Presentation 14/09/2015, page 8.2:
![]()
http://www.asx.com.au/asxpdf/20150914/pdf/43197pc2k0pp5k.pdf
My post was obviously based on the proviso of positive trial data and points to the fact that P&G are not the only ones that are very interested in the outcome of the BG trial. 'Three types of products for different market sectors' indicates on positive data that P&G will be negotiating at their best and Dr Steve Meller will be present to ensure that OBJ and Shareholders receive the best possible outcome on ALL fronts......including P&G's interest.
Add to My Watchlist
What is My Watchlist?